Market report
Dermatological drug tenders in Czechia — market report, March 2026
Dermatological drug tenders in Czechia in March 2026: 7,582 tenders published (+9% month on month, -14% year on year), estimated at €1,828,501 in total, and 7,586 contracts awarded (+10% month on month, -14% year on year), worth €32,119,827 (awarded value). Buyers with the most tenders: Krajská nemocnice T. Bati, a. s. (2,008), Krajská zdravotní, a.s. (881) and Fakultní nemocnice Bulovka (837); most contracts won: ViaPharma s.r.o. (184), AbbVie s.r.o. (138) and Janssen-Cilag s.r.o. (129). On average 1.4 bids per contract; 73% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 7,582
- Contracts awarded
- 7,586
- Contract value awarded
- €32,119,827
- Bids per contract
- 1.4
The highlighted bar is March 2026. Hover a bar for its figure; the table below has every value.
| Figure | March 2026 | February 2026 | Change | March 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 7,582 | 6,960 | +9% | 8,827 | -14% |
| Estimated value | €1,828,501 | €434,751 | +321% | €167,261 | +993% |
| Buyers | 34 | 30 | +13% | 34 | 0% |
| Contracts awarded | 7,586 | 6,903 | +10% | 8,846 | -14% |
| Contract value (awarded) | €32,119,827 | €20,170,723 | +59% | €26,562,599 | +21% |
| Winners | 310 | 295 | +5% | 279 | +11% |
| Bids per contract | 1.4 | 1.8 | — | 1.4 | — |
| Single-bid contracts | 73% | 52% | — | 75% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 184 |
| 2 | AbbVie s.r.o. | 138 |
| 3 | Janssen-Cilag s.r.o. | 129 |
| 4 | Takeda Pharmaceuticals Czech Republic s.r.o. | 126 |
| 5 | ROCHE s.r.o. | 108 |
| 6 | Amgen s.r.o. | 98 |
| 7 | Merck Sharp & Dohme s.r.o. | 93 |
| 8 | Avenier a.s. | 79 |
| 9 | ELI LILLY ČR, s.r.o. | 77 |
| 10 | BAYER s.r.o. | 72 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in March 2026?
- 7,582 (by 34 buyers); for comparison, February 2026: 6,960, March 2025: 8,827.
- Who won the most dermatological drug tenders in Czechia in March 2026?
- By number of contracts: ViaPharma s.r.o. (184), AbbVie s.r.o. (138), Janssen-Cilag s.r.o. (129), Takeda Pharmaceuticals Czech Republic s.r.o. (126) and ROCHE s.r.o. (108); 310 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in March 2026?
- Krajská nemocnice T. Bati, a. s. (2,008), Krajská zdravotní, a.s. (881), Fakultní nemocnice Bulovka (837), Fakultní nemocnice Brno (510) and Nemocnice České Budějovice, a.s. (360).
- How competitive were dermatological drug tenders in Czechia in March 2026?
- On average 1.4 bids per contract (15 contracts with a known number of bids); 73% of contracts had a single bid.
- What were the contracts worth in March 2026?
- €32,119,827 (awarded value, 7,586 contracts); median about €1,500,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.